Summary slides for "Systematic Review and Meta-Analysis Course for Healthcare Professionals", January 8-9, 2013, King Abdullah Medical City, Makkah, Saudi Arabia
http://KAMCResearch.org
Basics of Systematic Review and Meta-analysis: Part 3Rizwan S A
A 4 part lecture series on the basics of Systematic Review and Meta-analysis, Part 3 discusses the software needed and analytical techniques used for this purpose.
Critical Appraisal of systematic review and meta analysis articlesDr. Majdi Al Jasim
Critique of systematic review and meta analysis articles
This presentation is made to educate health care provide rs on how to do critical appraisal of systematic review and meta analysis articles
Summary slides for "Systematic Review and Meta-Analysis Course for Healthcare Professionals", January 8-9, 2013, King Abdullah Medical City, Makkah, Saudi Arabia
http://KAMCResearch.org
Basics of Systematic Review and Meta-analysis: Part 3Rizwan S A
A 4 part lecture series on the basics of Systematic Review and Meta-analysis, Part 3 discusses the software needed and analytical techniques used for this purpose.
Critical Appraisal of systematic review and meta analysis articlesDr. Majdi Al Jasim
Critique of systematic review and meta analysis articles
This presentation is made to educate health care provide rs on how to do critical appraisal of systematic review and meta analysis articles
Critical appraisal is the process of carefully and systematically analyze the research paper to judge its trustworthiness, its value and relevance in a particular context. (Amanda Burls 2009)
A critical review must identify the strengths and limitations in a research paper and this should be carried out in a systematic manner.
The Critical Appraisal helps in developing the necessary skills to make sense of scientific evidence, based on validity, results and relevance.
"Hierarchies of Evidence" is an important but problematic concept for medical professionals to understand as it underpins their capacity to be effective practitioners and researchers.
This workshop is meant to be an introduction to the systematic review process. Further information about systematic reviews was available through a research guide. http://libguides.ucalgary.ca/content.php?pid=593664
A systematic review (SR) is a rigorous and organized method to synthesize
the evidence from multiple studies on a particular research question or topic.
The purpose of a systematic review is to identify, appraise, and summarize all
available evidence relevant to a specific research question in a transparent
and replicable manner.
It aims to provide a comprehensive overview of academic literature
concerning a particular research question of topic.
This presentation explores the steps nee
SLC CME- Evidence based medicine 07/27/2007cddirks
Saint Luke's Care, a quality improvement organization within Saint Luke's Health System, presents a CME presentation by Dr. Brent Beasley on Evidence Based Medical Care.
Critical appraisal is the process of carefully and systematically analyze the research paper to judge its trustworthiness, its value and relevance in a particular context. (Amanda Burls 2009)
A critical review must identify the strengths and limitations in a research paper and this should be carried out in a systematic manner.
The Critical Appraisal helps in developing the necessary skills to make sense of scientific evidence, based on validity, results and relevance.
"Hierarchies of Evidence" is an important but problematic concept for medical professionals to understand as it underpins their capacity to be effective practitioners and researchers.
This workshop is meant to be an introduction to the systematic review process. Further information about systematic reviews was available through a research guide. http://libguides.ucalgary.ca/content.php?pid=593664
A systematic review (SR) is a rigorous and organized method to synthesize
the evidence from multiple studies on a particular research question or topic.
The purpose of a systematic review is to identify, appraise, and summarize all
available evidence relevant to a specific research question in a transparent
and replicable manner.
It aims to provide a comprehensive overview of academic literature
concerning a particular research question of topic.
This presentation explores the steps nee
SLC CME- Evidence based medicine 07/27/2007cddirks
Saint Luke's Care, a quality improvement organization within Saint Luke's Health System, presents a CME presentation by Dr. Brent Beasley on Evidence Based Medical Care.
Evidence-based Entrepreneurship by Steve Blank
Steve Blank @sgblank Stanford / Berkeley / Columbia
The Lean Startup Conference 2013
http://leanstartup.co/
Evidence based medicine, by prof Badr Mesbah. Professor of pediatric, Suez canal university
Lecture presented in Port said fourth neonatology conference, 24-25 October 2013, Port said, Egypt
Study designs, Epidemiological study design, Types of studiesDr Lipilekha Patnaik
Study design, Epidemiological study designA study design is a specific plan or protocol
for conducting the study, which allows the investigator to translate the conceptual hypothesis into an operational one.
Observational research designs are those in which the researcher/investigator merely observes and does not carry out any interventions/actions.
to change the result. The three most common types of observational studies are cross-sectional studies, case-control studies, and cohort (or longitudinal) studies.
In cross-sectional studies, exposure/risk factors and outcomes are determined at a single point in time. You can bid
information on disease prevalence and an overview of likely relationships that can be used to form a hypothesis. Control cases In
studies, participants are selected based on the presence/absence of an outcome and risk factors are identified during the study.
after enrollment of study participants.The relationship between exposure and outcome is reported as an odds ratio. This research; However,
carries a high risk of bias, which should be taken into account when designing the study. Cohort studies are prospective and include participants
were selected based on presence/absence of exposure and results were obtained at the end of the study. This research can deliver The incidence/impact of the disease and the relationship between exposure and outcome are presented as relative risks. They are useful
establish causality.A problem that arises in these studies could be the high fluctuation and dropout of study participants.
Descriptive studies generally describe the magnitude of a problem and characteristics of the population/individuals.
The various types of such studies include
case reports
case series or surveys.
A case report generally describes a patient presenting with an unusual disease, or simultaneous occurrence of more than one condition, or uncommon clinical features in a known disease.
A case series is a collection of similar cases. Such studies, other than providing some advancement to knowledge of a disease, are of limited value. Another method often used in epidemiological health care research is conducting surveys.
Surveys are done during a defined time-period and information on several variables of interest is collected from the target population. They provide estimates of prevalence of the various variables of interest, and their distribution. Such studies could also provide insight into individual opinions and practices. Advantages include ease of conduct and cost efficiency. The disadvantages include low response rates and a variety of biases.
An analytical study tests a hypothesis to determine an association between two or more variables, like causation, risk, or effect. Such studies have two or more study groups for comparison.
The primary focus of this article will be the three most common types of analytical observational studies –
cross-sectional,
case control (also known as retrospective) and
cohort (or longitudinal, also known as prospective) studies.
It may be pertinent to note that the primary objective of most clinical studies is to determine one of the following - burden of disease (prevalence
The most ambitious definition of health is that proposed by WHO in 1948: “health is a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity.” but,
Practical definitions of health and disease are needed in epidemiology, which concentrates on aspects of health that are easily measurable and amenable to improvement.
Definitions of health states used by epidemiologists tend to be simple.
Similar to HLinc presentation: levels of evidence (20)
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
2. What are levels of evidence?
The hierarchy is not an absolute measure of evidence. It
is a logical way to demonstrate the differing strengths of
studies.
2
Study quality and
reliability
Susceptibility to
bias
3. What do you mean by bias?
Bias is any influence (systematic error) in the conduct of
the study that effects the outcome.
Bias in quantitative studies:
Selection bias: how subjects were chosen to be studied
Allocation bias: how the subjects were assembled into groups
Attrition bias: accounting for subjects at the close of the study
Confounding: other issues present that effect the intervention and
outcome being studied (randomisation aims to reduce this risk)
Detection bias: the blinding of assessors to which result comes from
what group aims to reduce this
Data Collection: were valid and reliable instruments used to assess
outcomes?
Statistical Analysis: did the study have enough power (the sample
size) to detect an effect
3Integrity of intervention: was the intervention carried out as planned?
4. That pyramid thing again …
For commonly encountered clinical questions about
interventions, I look for …
4
Not much information in
this category but high
likelihood of clinical
relevance
Lots of information in
this category: ideas
and lab research
category, or expert
opinion category
6. Systematic Reviews & Meta-analysis
A systematic review is a type of literature review that asks a focused
question or questions. Explicit methods are used to identify,
appraise, select and synthesise all high-quality evidence relevant to
the question/s. These methods are rigorous and transparent. Some
systematic reviews include meta-analysis. This is a statistical
process where all study results are pooled and analysed. Systematic
reviews should, but do not always, employ a librarian to develop
exhaustive search strategies that cover relevant information sources,
employ relevant thesaurus terms and keywords, and use appropriate
filters. To assess whether a systematic review is current, the date
when the search strategy was last run should be checked.
Systematic reviews are good for answering intervention questions.
Meta-analysis – A systematic review that summarizes and analyses
statistics from studies included in the review (some statisticians rank
this as above the level of Systematic Review).
6
7. Randomised Controlled Trials
Uses a control and an experimental group to which
participants are randomly assigned, with a comparison
made at the end of the study. Assessors and researchers
administering the interventions may be blinded also.
RCTs are mainly used for intervention/therapy studies.
Advantages: assessing causality, and clearly
demonstrating that the intervention caused the results.
Disadvantages: expense, time-consumption, and risk of
bias if participants are not properly blinded. RCTs also
have the disadvantage in that the patient group selected
may not be clinically relevant.
7
8. Cohort and case control studies
Cohort Studies – Groups of individuals are followed over time
before they develop a disease/s or experience outcome/s of an
exposure. Cohort studies answer diagnostic test accuracy questions,
aetiology/risk questions for common outcomes resulting from
unusual exposure and longitudinal cohorts for prognosis questions.
Advantages: Researchers can identify relative risk of developing a
disease based on different exposures. Disadvantages: time and cost.
Case-control Studies – Patients with the same condition are
matched with controls. These studies begin with the outcomes. The
cases are reviewed to identify what experiences they had. These are
then compared with the control. They compare the odds of having an
experience with the outcome to the odds of having an experience
without the outcome. Case-control studies are good for answering
aetiology/ risk questions where a rare outcome resulted from a
common exposure.
8
9. Applying Levels of Evidence
The type of study you would
look for in the primary
literature depends on the
question being asked. The
table below summarizes
thinking on the best research
study designs corresponding
to common categories of
clinical questions.
9
12. What are n-of-1 trials?
Elizabeth O Lillie, Bradley Patay, Joel Diamant etal. The n-of-1 clinical
trial: the ultimate strategy for individualizing medicine? Per Med.
Mar 2011; 8(2): 161–173.
Abstract: N-of-1 or single subject clinical trials consider an individual
patient as the sole unit of observation in a study investigating the
efficacy or side-effect profiles of different interventions. The ultimate
goal of an n-of-1 trial is to determine the optimal or best intervention
for an individual patient using objective data-driven criteria. Such
trials can leverage study design and statistical techniques associated
with standard population-based clinical trials, including
randomization, washout and crossover periods, as well as placebo
controls. Despite their obvious appeal and wide use in educational
settings, n-of-1 trials have been used sparingly in medical and
general clinical settings.
12
16. JBI. (2000). Appraising systematic
reviews. Changing Practice: evidence
based practice sheets for health
professionals, Supplement 1, 1-6.
http://connect.jbiconnectplus.org/ViewS
ourceFile.aspx?0=4311
16
17. What are grades of recommendation then?
This is a method used by guideline developers to give a
judgement / grade to the body of evidence underpinning
each recommendation per clinical question.
GRADE - Grading of Recommendations Assessment,
Development and Evaluation (short GRADE) Working
Group
NHMRC – 2009 Levels of Evidence and Grades of
Recommendation rev ed
17
21. And another system …
Owens DK, Lohr KN, Atkins D, etal. J Clin Epidemiol. 2010
May;63(5):513-23. AHRQ series paper 5: grading the
strength of a body of evidence when comparing medical
interventions--agency for healthcare research and quality
and the effective health-care program.
http://www.ncbi.nlm.nih.gov/pubmed/19595577
RESULTS: The EPC approach is conceptually similar to the GRADE
system of evidence rating; it requires assessment of four domains:
risk of bias, consistency, directness, and precision. Additional
domains to be used when appropriate include dose-response
association, presence of confounders that would diminish an
observed effect, strength of association, and publication bias.
Strength of evidence receives a single grade: high, moderate, low, or
insufficient. We give definitions, examples, mechanisms for scoring
domains, and an approach for assigning strength of evidence.
21
22. History stuff
First introduced by Stephen Toulmin in 1976 in the
Journal of Medicine and Philosophy: On the Nature of the
Physician's Understanding
http://jmp.oxfordjournals.org/content/1/1/32.extract
In 1979, the Canadian Task Force on the Periodic Health
Examination published one of the first efforts to explicitly
characterise the level and strength of evidence
underlying healthcare recommendations: The periodic
health examination. Canadian Task Force on the Periodic
Health Examination
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1704686/?t
ool=pubmed
22